HBM Healthcare Valuation
| HBMN Stock | CHF 175.60 5.80 3.20% |
At this time, the entity appears to be fairly valued. HBM Healthcare Inves retains a regular Real Value of ₣174.54 per share. The prevalent price of the entity is ₣175.6. Our model calculates the value of HBM Healthcare Inves from inspecting the entity fundamentals such as current valuation of 2.49 B, and Shares Outstanding of 6.96 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that HBM Healthcare's price fluctuation is very steady at this time. Calculation of the real value of HBM Healthcare Inves is based on 3 months time horizon. Increasing HBM Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the HBM stock is determined by what a typical buyer is willing to pay for full or partial control of HBM Healthcare Investments. Since HBM Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HBM Stock. However, HBM Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 175.6 | Real 174.54 | Hype 175.6 | Naive 170.79 |
The intrinsic value of HBM Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence HBM Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of HBM Healthcare Investments helps investors to forecast how HBM stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HBM Healthcare more accurately as focusing exclusively on HBM Healthcare's fundamentals will not take into account other important factors: HBM Healthcare Total Value Analysis
HBM Healthcare Investments is currently anticipated to have takeover price of 2.49 B with market capitalization of 1.48 B, debt of 148.92 M, and cash on hands of 5.39 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the HBM Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.49 B | 1.48 B | 148.92 M | 5.39 M |
HBM Healthcare Investor Information
About 17.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. HBM Healthcare Inves recorded a loss per share of 11.22. The entity last dividend was issued on the 30th of August 2022. Based on the measurements of operating efficiency obtained from HBM Healthcare's historical financial statements, HBM Healthcare Investments is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.HBM Healthcare Asset Utilization
One of the ways to look at asset utilization of HBM is to check how much profit was generated for every dollar of assets it reports. HBM Healthcare Inves retains a negative application of resources of -0.14 (percent), losing ₣0.001396 for each franc of resources held by the entity. Unproductive asset utilization attests that the company is being less productive with each franc of resources it retains. Simply put, asset utilization of HBM Healthcare Investments shows how inefficient it operates for each franc spent on its resources.HBM Healthcare Ownership Allocation
The market capitalization of HBM Healthcare is ₣1.48 Billion. HBM Healthcare Inves retains 16.89 (percent) of its outstanding shares held by insiders and 4.76 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.HBM Healthcare Profitability Analysis
Net Loss for the year was (78.03 M) with loss before overhead, payroll, taxes, and interest of (73.78 M).About HBM Healthcare Valuation
Our relative valuation model uses a comparative analysis of HBM Healthcare. We calculate exposure to HBM Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HBM Healthcare's related companies.HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund exits its portfolio companies through trade sale or IPO. HBM Healthcare operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange.
8 Steps to conduct HBM Healthcare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HBM Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HBM Healthcare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain HBM Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine HBM Healthcare's revenue streams: Identify HBM Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research HBM Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish HBM Healthcare's growth potential: Evaluate HBM Healthcare's management, business model, and growth potential.
- Determine HBM Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HBM Healthcare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for HBM Stock Analysis
When running HBM Healthcare's price analysis, check to measure HBM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HBM Healthcare is operating at the current time. Most of HBM Healthcare's value examination focuses on studying past and present price action to predict the probability of HBM Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HBM Healthcare's price. Additionally, you may evaluate how the addition of HBM Healthcare to your portfolios can decrease your overall portfolio volatility.